JBS N.V.

JBS N.V. runs more than 250 slaughtering and processing plants across beef, pork, poultry, and leather, where each facility holds its own government inspection approval — from the USDA, Brazilian MAPA, or equivalent agencies — and those approvals cannot be transferred or pooled, so the entire business is built around keeping every certified line running continuously because live animals cannot simply be held at the gate waiting. Because carcasses degrade on a fixed biological clock, each plant feeds directly into a cold-chain whose transit windows are dictated by protein spoilage rates rather than by customer demand, binding the whole network to the speed of refrigerated logistics. Owning certified facilities across all four protein categories inside one shared cold-chain means that when African swine fever shuts a pork export corridor or a beef recall pulls one product line, JBS can redirect refrigerated capacity and facility throughput toward the unaffected categories — a reallocation a single-protein competitor simply cannot make because it holds certifications in only one animal class. The fragility runs in the same direction as the advantage: if a disease outbreak triggers regulatory market closures across beef, pork, and poultry simultaneously, the shared infrastructure that normally allows rerouting instead becomes one large surface across which revenue loss and contamination risk spread together, and the multi-protein hedge disappears at exactly the moment it would have been most useful.